Invesco Ltd. Kodiak Sciences Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Invesco Ltd. holds 519,010 shares of KOD stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

519,010

Previous 80,375 545.74%

Holding current value

$2.73 Million

Previous $209,000 2370.81%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.6 - $10.9 $1.14 Million - $4.78 Million	438,635 Added 545.74%	519,010 $5.16 Million
Q3 2024 Nov 12, 2024	BUY	$2.2 - $3.25 $10,797 - $15,951	4,908 Added 6.5%	80,375 $209,000
Q2 2024 Aug 13, 2024	SELL	$2.29 - $4.48 $1.44 Million - $2.82 Million	-629,850 Reduced 89.3%	75,467 $177,000
Q1 2024 May 14, 2024	BUY	$3.01 - $7.45 $1.88 Million - $4.66 Million	626,122 Added 790.61%	705,317 $3.71 Million
Q4 2023 Feb 12, 2024	BUY	$1.4 - $3.24 $672 - $1,555	480 Added 0.61%	79,195 $240,000
Q3 2023 Nov 13, 2023	BUY	$1.8 - $7.49 $17,717 - $73,724	9,843 Added 14.29%	78,715 $141,000
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $14,667 - $32,336	3,411 Added 5.21%	68,872 $475,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $199,667 - $368,617	41,511 Added 173.32%	65,461 $405,000
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.05 $665 - $821	-102 Reduced 0.42%	23,950 $171,000
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $5,980 - $9,875	-790 Reduced 3.18%	24,052 $186,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $1,421 - $2,673	-282 Reduced 1.12%	24,842 $190,000
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $3.81 Million - $48 Million	-537,033 Reduced 95.53%	25,124 $194,000
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $488,091 - $775,694	-6,037 Reduced 1.06%	562,157 $47.7 Million
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $15.1 Million - $19.7 Million	184,682 Added 48.16%	568,194 $54.5 Million
Q2 2021 Aug 17, 2021	BUY	$77.2 - $126.54 $232,680 - $381,391	3,014 Added 0.79%	383,512 $35.7 Million
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $6.15 Million - $9.15 Million	-55,639 Reduced 12.76%	380,498 $43.1 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $26.5 Million - $67.2 Million	436,137 New	436,137 $64.1 Million
Q3 2020 Nov 16, 2020	SELL	$45.05 - $59.27 $1.63 Million - $2.15 Million	-36,281 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $119,714 - $185,566	-2,801 Reduced 7.17%	36,281 $1.96 Million
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $2.31 Million - $4.47 Million	-60,437 Reduced 60.73%	39,082 $1.87 Million
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $615,533 - $3.39 Million	44,283 Added 80.17%	99,519 $7.16 Million
Q3 2019 Nov 14, 2019	BUY	$10.24 - $17.57 $565,616 - $970,496	55,236 New	55,236 $794,000

Others Institutions Holding KOD

# of Institutions

109

Shares Held

40.9M

Call Options Held

28.4K

Put Options Held

21.2K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $274M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account